StonvexLoading…
StonvexStonvexStonvexCore line items from SPCE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.54M | $7.04M | $6.80M | $2.31M |
Operating Income | $-285.34M | $-376.63M | $-531.51M | $-499.98M |
Net Income | $-278.91M | $-346.74M | $-502.34M | $-500.15M |
EPS (Diluted) | $-5.44 | $-13.89 | $-29.79 | $-1.89 |
Total Assets | $803.18M | $961.23M | $1.18B | $1.14B |
Total Liabilities | $529.22M | $638.95M | $674.04M | $659.72M |
Cash & Equivalents | $144.73M | $178.60M | $216.80M | $302.29M |
Free Cash Flow OCF − CapEx | $-438.19M | $-474.56M | $-492.50M | $-396.73M |
Shares Outstanding | 73.33M | 33.00M | 20.00M | 275.40M |